186 related articles for article (PubMed ID: 32571097)
1. Cardiac hypertrophic risk markers of left ventricle and left atrium in chronic heart failure due to aortic and mitral valve disease.
Jan MI; Khan RA; Khan N; Mahak A; Shah AUHA; Hussain ST; Kakakhel AU; Murtaza I
Acta Radiol; 2021 May; 62(5):603-609. PubMed ID: 32571097
[TBL] [Abstract][Full Text] [Related]
2. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
[TBL] [Abstract][Full Text] [Related]
3. Correlation between plasma N-terminal pro-brain natriuretic peptide levels and changes in New York Heart Association functional class, left atrial size, left ventricular size and function after mitral and/or aortic valve replacement.
Elasfar A
Ann Saudi Med; 2012; 32(5):469-72. PubMed ID: 22871614
[TBL] [Abstract][Full Text] [Related]
4. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
[TBL] [Abstract][Full Text] [Related]
5. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
[TBL] [Abstract][Full Text] [Related]
6. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction.
Matsumoto A; Hirata Y; Momomura S; Suzuki E; Yokoyama I; Sata M; Ohtani Y; Serizawa T
Am Heart J; 1995 Jan; 129(1):139-45. PubMed ID: 7817907
[TBL] [Abstract][Full Text] [Related]
7. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
[TBL] [Abstract][Full Text] [Related]
9. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
[TBL] [Abstract][Full Text] [Related]
10. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
[TBL] [Abstract][Full Text] [Related]
11. Role of right and left atrial dimensions for release of atrial natriuretic peptide in left-sided valvular heart disease and idiopathic dilated cardiomyopathy.
Haass M; Dietz R; Fischer TA; Lang RE; Kübler W
Am J Cardiol; 1988 Oct; 62(10 Pt 1):764-70. PubMed ID: 2971311
[TBL] [Abstract][Full Text] [Related]
12. NT-pro-brain natriuretic peptide levels after valve replacement.
Elasfar AA
Asian Cardiovasc Thorac Ann; 2011 Dec; 19(6):399-402. PubMed ID: 22160408
[TBL] [Abstract][Full Text] [Related]
13. [Increased concentrations of atrial natriuretic peptide in the plasma and heart atrium of patients with aortic and mitral valve diseases compared to patients with coronary heart disease].
Wambach G; Hannekum A; Schmidt S; Kaufmann W; Dalichau H
Z Kardiol; 1987 Feb; 76(2):76-80. PubMed ID: 2953121
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
[TBL] [Abstract][Full Text] [Related]
15. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
16. [Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people].
Mabuchi N; Tsutamoto T; Maeda K; Masahiko K
Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):535-40. PubMed ID: 11031826
[TBL] [Abstract][Full Text] [Related]
17. Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease.
Sato M; Mikamo A; Kurazumi H; Suzuki R; Murakami M; Kobayashi T; Yoshimura K; Hamano K
J Cardiothorac Surg; 2013 Feb; 8():32. PubMed ID: 23448148
[TBL] [Abstract][Full Text] [Related]
18. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
[TBL] [Abstract][Full Text] [Related]
19. Determinants of the reduction in B-type natriuretic peptide after mitral valve replacement in patients with rheumatic mitral stenosis.
Leszek P; Klisiewicz A; Janas J; Różański J; Rywik T; Piotrowski W; Korewicki J
Clin Physiol Funct Imaging; 2010 Nov; 30(6):473-9. PubMed ID: 20807228
[TBL] [Abstract][Full Text] [Related]
20. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
